Alexium International Group Ltd (ASX: AJX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Alexium International Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $15.62 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.56 billion
Earnings per share -0.004
Dividend per share N/A
Year To Date Return -28.57%
Earnings Yield N/A
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Alexium International Group Ltd (ASX: AJX)
    Latest News

    a woman
    ⏸️ Investing

    10 S&P/ASX 300 growth shares with big potential

    The S&P/ASX 300 (Index:^AXKO)(ASX:XKO) has been rebalanced. 1-Page Ltd (ASX:1PG), 3P Learning Limited (ASX:3PL), a2 Milk Company Ltd (Australia) (ASX:A2M)…

    Read more »

    a woman
    ⏸️ Investing

    5 ASX stocks that have gained more than 300% in the past year

    The Markets might be volatile but these five companies have still managed to gain more than 300% in the past…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX stocks are soaring today

    Alexium International Group Ltd (ASX:AJX) and Magellan Financial Group Ltd (ASX:MFG) are among today's big winners.

    Read more »

    a woman
    ⏸️ Investing

    5 stocks sinking on the ASX today

    S&P/ASX 300 closes up 0.5%, but these 5 fell more than 8%

    Read more »

    a woman
    ⏸️ Investing

    4 ASX stocks hammered down today

    The ASX's All Ordinaries index sinks 0.5%, but these four were dealt a bigger blow

    Read more »

    a woman
    ⏸️ Investing

    4 stocks soaring on the ASX today

    S&P/ALL Ordinaries closes flat, but these four jumped more than 11%

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Mar 2004 $0.0200 100.00% Interim 15 Apr 2004

    AJX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Alexium International Group Ltd

    Alexium International Group Ltd is engaged in the development of specialty chemicals. Its only operating segment is the development and commercialization of its proprietary flame retardant (FR) and phase change material (PCM) chemistries, cooling products for bedding, and selling its specialized chemistry to customers. Geographically, it derives a majority of its revenue from the United States and also has a presence in Australia. The company products include Alexicool and Alexiflam NF.

    AJX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    19 Jul 2024 $0.01 $0.00 0.00% 281,400 $0.01 $0.01 $0.01
    18 Jul 2024 $0.01 $0.00 0.00% 220,436 $0.01 $0.01 $0.01
    16 Jul 2024 $0.01 $0.00 0.00% 15,400 $0.01 $0.01 $0.01
    15 Jul 2024 $0.01 $0.00 0.00% 50,000 $0.01 $0.01 $0.01
    12 Jul 2024 $0.01 $0.00 0.00% 10,750 $0.01 $0.01 $0.01
    11 Jul 2024 $0.01 $0.00 0.00% 32,500 $0.01 $0.01 $0.01
    10 Jul 2024 $0.01 $0.00 0.00% 199,983 $0.01 $0.01 $0.01
    09 Jul 2024 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    08 Jul 2024 $0.01 $0.00 0.00% 134,334 $0.01 $0.01 $0.01
    03 Jul 2024 $0.01 $0.00 0.00% 108,753 $0.01 $0.01 $0.01
    02 Jul 2024 $0.01 $0.00 0.00% 143,250 $0.01 $0.01 $0.01
    01 Jul 2024 $0.01 $0.00 0.00% 84,346 $0.01 $0.01 $0.01
    28 Jun 2024 $0.01 $0.00 0.00% 207,567 $0.01 $0.01 $0.01
    27 Jun 2024 $0.01 $0.00 0.00% 107,473 $0.01 $0.01 $0.01
    26 Jun 2024 $0.01 $0.00 0.00% 161,998 $0.01 $0.01 $0.01
    25 Jun 2024 $0.01 $0.00 0.00% 709,528 $0.01 $0.01 $0.01
    24 Jun 2024 $0.01 $0.00 0.00% 665,092 $0.01 $0.01 $0.01
    21 Jun 2024 $0.01 $0.00 0.00% 46,060 $0.01 $0.01 $0.01
    20 Jun 2024 $0.01 $0.00 0.00% 1,509,822 $0.01 $0.01 $0.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 May 2024 Simon Moore Issued 4,184,624 $46,030
    Director remuneration.
    08 May 2024 Simon Moore Buy 549,306,692 $8,239,600
    Conversion of convertible notes.
    07 May 2024 Simon Moore Issued 19,939,214 $259,209
    Placement.
    07 May 2024 Carl Dennis Issued 14,954,410 $94,407
    Placement. As per announcement on 09-05-2024
    06 May 2024 Carl Dennis Issued 171,144 $2,224
    Rights issue.
    06 May 2024 Carl Dennis Issued 100,430,205 $1,305,592
    Rights issue.
    06 May 2024 Simon Moore Issued 133,906,940 $1,740,790
    Rights issue.
    03 May 2024 Robert (Bob) Brookins Issued 3,850,000 $50,050
    Placement. As per announcement on 03-05-2024
    03 May 2024 Paul Stenson Issued 11,500,000 $149,500
    Placement.
    03 May 2024 William (Billy) Blackburn Issued 12,000,000 $156,000
    Placement.
    12 Jan 2024 William (Billy) Blackburn Issued 6,712,233 $93,971
    Issue of securities. 29,555,881 Share Appreciation Rights
    12 Jan 2024 Robert (Bob) Brookins Issued 6,505,703 $91,079
    Issue of securities. 19,882,851 Share Appreciation Rights
    29 Sep 2023 Rosheen Garnon Issued 3,853,481 $66,279
    Director remuneration. Estimated value
    29 Sep 2023 Simon Moore Issued 3,013,895 $51,838
    Director remuneration. Estimated value

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Simon Colinton Moore Non-Executive DirectorInterim Chairman Feb 2020
    Mr Moore is the Senior Partner of the investment firm, Colinton Capital Partners. Prior to establishing Colinton Capital Partners in 2017, Mr Moore was a Global Partner of The Carlyle Group having established their operation in Australia in 2005. In his time at The Carlyle Group, he oversaw the Firm's investments in and served on the Boards of Directors of Coates Hire, Healthscope and Qube. Mr Moore is currently Chair of the Audit Committee and a member of the Risk Committees.
    Dr Robert (Bob) Brookins Executive Director May 2018
    Dr Brookins has more than 15 years of experience in organic synthesis and materials chemistry. Upon completion of his PhD, he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed synthetic routes for reactive and functional surfaces. In 2010, Dr Brookins joined Alexium where he and his team pioneered new classes of flame-retardants for textile markets. Additionally, his research focuses on phase change materials, particularly application methods and analytical tools.
    Dr Paul Henry Stenson Non-Executive Director Jun 2020
    Dr Stenson is the chair of the Risk Committee. Dr Stenson has a career with the research, development, manufacture, and commercialisation of new materials in the fields of coatings, adhesives, nonwovens, and pharmaceuticals.
    Mr Carl Bradley Dennis Non-Executive Director Sep 2021
    Mr Dennis is an operational management professional with over 25 years of experience with expertise in Consumer and Pharmaceutical Goods. As a former CEO and commercial director, Mr Dennis has skills in new product development, sales and marketing, international brand management and operational execution. Mr Dennis was the CEO and co-owner of Vital Merchandising Services Pty Ltd for 11 years which was acquired by Imperial Logistics Limited in 2007 and he went on to hold both operational and business development C-suite roles with Imperial Logistics as part of the DP World Group. Throughout his career, his clients have included Blue Chip FMCG organisations with global brands. Over the past seven years Mr Dennis has focused on creating new markets for international Australian consumer brands across Asia, the Middle East, and Africa.
    Mr William (Billy) Timothy Blackburn Chief Executive OfficerManaging Director Sep 2022
    Mr Blackburn has over 25-years of experience in general management, with record of driving commercial growth. He has enjoyed accomplishment as both an entrepreneur and as an executive in organizations. He founded Emes, a technology-based specialty chemical business. Emes had a business model focused on chemical production paired with recycling in the pharmaceutical and consumer healthcare markets. Mr. Blackburn sold the business to Nova Molecular. He joined their executive team to lead further commercial growth of the merged organisations.
    Mr T Randall Lane Non-Executive Director Jul 2024
    --
    Mr Martyn Strickland Non-Executive Director Jul 2024
    --
    Mr Mark Andrew Licciardo Company Secretary Mar 2020
    -
    Jason Lewis Chief Financial Officer
    -
    Robert Brookins Chief Technology Officer
    -
    Mark Andrew Licciardo Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Colinton Capital Partners Pty Ltd <Colinton Cp Fund 1 (A) A/C> 79,151,331 12.15%
    Sandhurst Trustees Ltd <Wentworth Williamson A/C> 55,188,743 8.47%
    Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips Pens F A/C> 43,725,000 6.71%
    Dr Stuart Lloyd Phillips & Mrs Fiona Jane Phillips <Sl & Fj Phillips S/F A/C> 30,800,000 4.73%
    BNP Paribas Nominees Pty Ltd ACF Clearstream 24,767,436 3.80%
    Dr Elyse Jane Phillips 10,475,000 1.61%
    Hsbc Custody Nominees (Australia) Limited <Gsco Customers A/C> 10,000,000 1.54%
    N & G Td Proprietary Limited <N & G Td Super Fund A/C> 10,000,000 1.54%
    Ducky'S Lifeline Pty Ltd <The R Edwards Super A/C> 8,320,552 1.28%
    Bnp Paribas Noms Pty Ltd <Drp> 8,314,657 1.28%
    Lucky Pom Pty Limited <Grayson A/C> 8,000,000 1.23%
    Citicorp Nominees Pty Limited 6,644,867 1.02%
    Mabeth Pty Ltd 6,000,000 0.92%
    Mr Ian Morton & Mrs Deborah Morton <Debian Super Fund A/C> 5,673,285 0.87%
    Mr Martin Keith Thomas & Mrs Helen Patricia Thomas 5,431,500 0.83%
    Lomand Services Limited 5,081,500 0.78%
    D & M Mowbray Holdings Pty Ltd 5,000,000 0.77%
    Rosheen Garnon 4,676,724 0.72%
    Cannow Pty Ltd <C & T Family S/Fund A/C> 4,400,000 0.68%
    Ms Frances Elizabeth Phillips & Mr Stuart Lloyd Phillips <Francesphillipssuperfnd A/C> 3,903,000 0.60%
    Radell Pty Limited <The Mackay Family Super A/C> 3,500,000 0.54%

    Profile

    since

    Note